Testing effectiveness (Phase 2)Study completedNCT05596734
What this trial is testing
Evaluate the Safety, Tolerability, and Immunogenicity of Combined Modified RNA Vaccine Candidates Against COVID-19 and Influenza
Who this might be right for
Influenza, HumanCOVID-19
BioNTech SE 1,019